Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000932799-08-000130
Filing Date
2008-06-12
Accepted
2008-06-12 15:12:23
Documents
1
Period of Report
2008-06-10

Document Format Files

Seq Description Document Type Size
1 bartholdson_ex.html 4  
1 bartholdson_ex.xml 4 4302
  Complete submission text file 0000932799-08-000130.txt   6107
Mailing Address 310 GOLDEN SHORE LONG BEACH CA 90802
Business Address 310 GOLDEN SHORE LONG BEACH CA 90802 562-628-1007
Obagi Medical Products, Inc. (Issuer) CIK: 0001375247 (see all company filings)

EIN.: 954658730 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STONINGTON PARTNERS, INC. 540 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 212-339-8500
Bartholdson John A. (Reporting) CIK: 0001382909 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33204 | Film No.: 08895610